GTX, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 30225
 
  
 
C07D HETEROCYCLIC COMPOUNDS 15147
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 12126
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A47J KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES 149

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0106,702 METHODS OF TREATING UROLOGICAL DISORDERS USING SARMsOct 16, 15Apr 21, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9834507 Selective androgen receptor degrader (SARD) ligands and methods of use thereofOct 21, 16Dec 05, 17[A61K, C07C]
9814698 Selective androgen receptor degrader (SARD) ligands and methods of use thereofApr 21, 16Nov 14, 17[A61K]
9815776 Selective androgen receptor degrader (SARD) ligands and methods of use thereofApr 21, 16Nov 14, 17[A61K, C07C]
9744149 Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)Jul 13, 15Aug 29, 17[A61K]
9622992 Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)Jun 02, 14Apr 18, 17[A61K]
9623021 Nuclear receptor binding agentsMay 04, 10Apr 18, 17[A61K, C07D]
9624161 Estrogen receptor ligands and methods of use thereofOct 24, 14Apr 18, 17[A61K, C07D, C07C]
9604916 Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)Mar 07, 13Mar 28, 17[A61K, C07C]
9604931 Nuclear receptor binding agentsOct 15, 12Mar 28, 17[A61K, C07D]
9447049 Compounds for treatment of cancerNov 14, 12Sep 20, 16[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0014,401 NUCLEAR RECEPTOR BINDING AGENTSAbandonedFeb 09, 16Jan 19, 17[A61K]
2014/0187,641 ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOFAbandonedDec 23, 13Jul 03, 14[A61K, C07C]
2014/0057,946 ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOFAbandonedFeb 13, 13Feb 27, 14[C07D, C07C]
2014/0057,985 ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOFAbandonedDec 13, 12Feb 27, 14[A61K, C07C]
8637706 Nuclear receptor binding agentsExpiredJan 31, 12Jan 28, 14[A61K, C07C]
2013/0122,085 PHARMACEUTICAL COMPOSITIONS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOFAbandonedNov 01, 12May 16, 13[A61K]
7776921 Treating benign prostate hyperplasia with SARMSExpiredFeb 06, 03Aug 17, 10[A61K]
7524866 Prevention and treatment of androgen—deprivation induced osteoporosisExpiredFeb 17, 04Apr 28, 09[A61K]
2009/0062,341 Nuclear receptor binding agentsAbandonedNov 28, 06Mar 05, 09[A61K, C07D, C07C, C07K]
2008/0249,183 Treatment of androgen-deprivation induced osteoporosisAbandonedFeb 22, 08Oct 09, 08[A61K, A61P]
2007/0197,664 Prevention and treatment of androgen-deprivation induced osteoporosisAbandonedJan 23, 07Aug 23, 07[A61K]
2007/0135,407 Serm reduction of lipid profilesAbandonedNov 28, 06Jun 14, 07[A61K, A01N]
2006/0287,282 Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereofAbandonedDec 06, 04Dec 21, 06[A61K]
2006/0276,539 Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMSAbandonedJan 04, 06Dec 07, 06[A61K]
2006/0269,611 Prevention and treatment of androgen-deprivation induced osteoporosisAbandonedJan 11, 06Nov 30, 06[A61K]
2006/0258,628 Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereofAbandonedJul 20, 04Nov 16, 06[A61K]
2006/0019,931 Treating bone-related disorders with selective androgen receptor modulatorsAbandonedOct 12, 04Jan 26, 06[A61K]
2006/0019,989 Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereofAbandonedJul 21, 04Jan 26, 06[A61K]
2005/0209,320 Anti-cancer compounds and methods of use thereofAbandonedOct 14, 04Sep 22, 05[A61K]
6899888 Prevention and treatment of androgen-deprivation induced osteoporosisExpiredNov 27, 02May 31, 05[A61K, A61F]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.